"We owe it to our investors to make sure that we are focused in exploiting all of the additional patents inclusive of the children's products, security, and medical applications. As with our most recent security patent negotiations where we successfully gained upfront licensing fees and royalties, our negotiations with potential partners illustrate our commitment to executing the best agreements for REVO and its shareholders. We expect to complete these negotiations soon and look forward to announcing our efforts to the public," states Solomon RC Ali, Vice President.
